Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2013 | 1 |
2014 | 1 |
2015 | 2 |
2016 | 2 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
Page 1
Inhibition of breast cancer cell motility with a non-cyclooxygenase inhibitory derivative of sulindac by suppressing TGFβ/miR-21 signaling.
Oncotarget. 2016 Feb 16;7(7):7979-92. doi: 10.18632/oncotarget.6888.
Oncotarget. 2016.
PMID: 26769851
Free PMC article.
β-catenin nuclear translocation in colorectal cancer cells is suppressed by PDE10A inhibition, cGMP elevation, and activation of PKG.
Lee K, Lindsey AS, Li N, Gary B, Andrews J, Keeton AB, Piazza GA.
Lee K, et al.
Oncotarget. 2016 Feb 2;7(5):5353-65. doi: 10.18632/oncotarget.6705.
Oncotarget. 2016.
PMID: 26713600
Free PMC article.
Item in Clipboard
Suppression of β-catenin/TCF transcriptional activity and colon tumor cell growth by dual inhibition of PDE5 and 10.
Li N, Chen X, Zhu B, Ramírez-Alcántara V, Canzoneri JC, Lee K, Sigler S, Gary B, Li Y, Zhang W, Moyer MP, Salter EA, Wierzbicki A, Keeton AB, Piazza GA.
Li N, et al.
Oncotarget. 2015 Sep 29;6(29):27403-15. doi: 10.18632/oncotarget.4741.
Oncotarget. 2015.
PMID: 26299804
Free PMC article.
Item in Clipboard
Phosphodiesterase 10A: a novel target for selective inhibition of colon tumor cell growth and β-catenin-dependent TCF transcriptional activity.
Li N, Lee K, Xi Y, Zhu B, Gary BD, Ramírez-Alcántara V, Gurpinar E, Canzoneri JC, Fajardo A, Sigler S, Piazza JT, Chen X, Andrews J, Thomas M, Lu W, Li Y, Laan DJ, Moyer MP, Russo S, Eberhardt BT, Yet L, Keeton AB, Grizzle WE, Piazza GA.
Li N, et al.
Oncogene. 2015 Mar 19;34(12):1499-509. doi: 10.1038/onc.2014.94. Epub 2014 Apr 7.
Oncogene. 2015.
PMID: 24704829
Free PMC article.
Item in Clipboard
Sulindac selectively inhibits colon tumor cell growth by activating the cGMP/PKG pathway to suppress Wnt/β-catenin signaling.
Li N, Xi Y, Tinsley HN, Gurpinar E, Gary BD, Zhu B, Li Y, Chen X, Keeton AB, Abadi AH, Moyer MP, Grizzle WE, Chang WC, Clapper ML, Piazza GA.
Li N, et al.
Mol Cancer Ther. 2013 Sep;12(9):1848-59. doi: 10.1158/1535-7163.MCT-13-0048. Epub 2013 Jun 26.
Mol Cancer Ther. 2013.
PMID: 23804703
Free PMC article.
Item in Clipboard
Cite
Cite